Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Nosologic Comparisons of DSM-IV and DSM-5 Alcohol and Drug Use Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III.

Goldstein RB, Chou SP, Smith SM, Jung J, Zhang H, Saha TD, Pickering RP, Ruan WJ, Huang B, Grant BF.

J Stud Alcohol Drugs. 2015 May;76(3):378-88.

2.

Long-term test-retest reliability of striatal and extrastriatal dopamine D2/3 receptor binding: study with [(11)C]raclopride and high-resolution PET.

Alakurtti K, Johansson JJ, Joutsa J, Laine M, Bäckman L, Nyberg L, Rinne JO.

J Cereb Blood Flow Metab. 2015 Jul;35(7):1199-205. doi: 10.1038/jcbfm.2015.53. Epub 2015 Apr 8.

3.

Stereochemistry and neuropharmacology of a 'bath salt' cathinone: S-enantiomer of mephedrone reduces cocaine-induced reward and withdrawal in invertebrates.

Vouga A, Gregg RA, Haidery M, Ramnath A, Al-Hassani HK, Tallarida CS, Grizzanti D, Raffa RB, Smith GR, Reitz AB, Rawls SM.

Neuropharmacology. 2015 Apr;91:109-16. doi: 10.1016/j.neuropharm.2014.11.010. Epub 2014 Dec 9.

4.

In vivo imaging of cerebral dopamine D3 receptors in alcoholism.

Erritzoe D, Tziortzi A, Bargiela D, Colasanti A, Searle GE, Gunn RN, Beaver JD, Waldman A, Nutt DJ, Bani M, Merlo-Pich E, Rabiner EA, Lingford-Hughes A.

Neuropsychopharmacology. 2014 Jun;39(7):1703-12. doi: 10.1038/npp.2014.18. Epub 2014 Jan 28.

5.

Reduced ethanol consumption by alcohol-preferring (P) rats following pharmacological silencing and deep brain stimulation of the nucleus accumbens shell.

Wilden JA, Qing KY, Hauser SR, McBride WJ, Irazoqui PP, Rodd ZA.

J Neurosurg. 2014 Apr;120(4):997-1005. doi: 10.3171/2013.12.JNS13205. Epub 2014 Jan 24.

6.

Biomarkers for the development of new medications for cocaine dependence.

Bough KJ, Amur S, Lao G, Hemby SE, Tannu NS, Kampman KM, Schmitz JM, Martinez D, Merchant KM, Green C, Sharma J, Dougherty AH, Moeller FG.

Neuropsychopharmacology. 2014 Jan;39(1):202-19. doi: 10.1038/npp.2013.210. Epub 2013 Aug 27. Review.

7.

DSM-5 criteria for substance use disorders: recommendations and rationale.

Hasin DS, O'Brien CP, Auriacombe M, Borges G, Bucholz K, Budney A, Compton WM, Crowley T, Ling W, Petry NM, Schuckit M, Grant BF.

Am J Psychiatry. 2013 Aug;170(8):834-51. doi: 10.1176/appi.ajp.2013.12060782. Review.

8.

The clinical neurobiology of drug craving.

Sinha R.

Curr Opin Neurobiol. 2013 Aug;23(4):649-54. doi: 10.1016/j.conb.2013.05.001. Epub 2013 Jun 10. Review.

9.

The addicted brain.

Diana M.

Front Psychiatry. 2013 Jun 3;4:40. doi: 10.3389/fpsyt.2013.00040. eCollection 2013. No abstract available.

10.

Kappa-opioid receptor signaling in the striatum as a potential modulator of dopamine transmission in cocaine dependence.

Trifilieff P, Martinez D.

Front Psychiatry. 2013 Jun 3;4:44. doi: 10.3389/fpsyt.2013.00044. eCollection 2013.

11.

How does stress lead to risk of alcohol relapse?

Sinha R.

Alcohol Res. 2012;34(4):432-40. Review.

12.

Nanoparticle based galectin-1 gene silencing, implications in methamphetamine regulation of HIV-1 infection in monocyte derived macrophages.

Reynolds JL, Law WC, Mahajan SD, Aalinkeel R, Nair B, Sykes DE, Yong KT, Hui R, Prasad PN, Schwartz SA.

J Neuroimmune Pharmacol. 2012 Sep;7(3):673-85. doi: 10.1007/s11481-012-9379-7. Epub 2012 Jun 12.

13.

Neural correlates of stress-induced and cue-induced drug craving: influences of sex and cocaine dependence.

Potenza MN, Hong KI, Lacadie CM, Fulbright RK, Tuit KL, Sinha R.

Am J Psychiatry. 2012 Apr;169(4):406-14. doi: 10.1176/appi.ajp.2011.11020289.

14.

The dopamine hypothesis of drug addiction and its potential therapeutic value.

Diana M.

Front Psychiatry. 2011 Nov 29;2:64. doi: 10.3389/fpsyt.2011.00064. eCollection 2011.

15.

Deficits in dopamine D(2) receptors and presynaptic dopamine in heroin dependence: commonalities and differences with other types of addiction.

Martinez D, Saccone PA, Liu F, Slifstein M, Orlowska D, Grassetti A, Cook S, Broft A, Van Heertum R, Comer SD.

Biol Psychiatry. 2012 Feb 1;71(3):192-8. doi: 10.1016/j.biopsych.2011.08.024. Epub 2011 Oct 19.

16.

New findings on biological factors predicting addiction relapse vulnerability.

Sinha R.

Curr Psychiatry Rep. 2011 Oct;13(5):398-405. doi: 10.1007/s11920-011-0224-0. Review.

17.

Modeling relapse situations in the human laboratory.

Sinha R.

Curr Top Behav Neurosci. 2013;13:379-402. doi: 10.1007/7854_2011_150. Review.

18.

Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse.

Breese GR, Sinha R, Heilig M.

Pharmacol Ther. 2011 Feb;129(2):149-71. doi: 10.1016/j.pharmthera.2010.09.007. Epub 2010 Oct 15. Review.

19.

Influence of compulsivity of drug abuse on dopaminergic modulation of attentional bias in stimulant dependence.

Ersche KD, Bullmore ET, Craig KJ, Shabbir SS, Abbott S, Müller U, Ooi C, Suckling J, Barnes A, Sahakian BJ, Merlo-Pich EV, Robbins TW.

Arch Gen Psychiatry. 2010 Jun;67(6):632-44. doi: 10.1001/archgenpsychiatry.2010.60.

20.

Dopamine type 2/3 receptor availability in the striatum and social status in human volunteers.

Martinez D, Orlowska D, Narendran R, Slifstein M, Liu F, Kumar D, Broft A, Van Heertum R, Kleber HD.

Biol Psychiatry. 2010 Feb 1;67(3):275-8. doi: 10.1016/j.biopsych.2009.07.037. Epub 2009 Oct 6.

Supplemental Content

Support Center